News Sentiment

AVTR sentiment intelligence

Avantor Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 56 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 10.39 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.7% over one week, +10.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Is Avantor (AVTR) Quietly Redefining Its Healthcare Role With NuSil’s HIV-Prevention Partnership?

Market Reaction

Balanced read

47/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction 0.7% Price digesting
Trend fit Trend inactive 10.6% over four weeks
Fair value -41.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 25
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
simplywall.st 8
The National Law Review 5
Stock Titan 4
TradingView 4
ACCESS Newswire 4
Moomoo 3
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 13
Regulatory and legal 9
Deals and strategy 5
Analyst action 4
Macro sensitivity 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
The National Law Review Direct company coverage

AVTR Shareholders Have Opportunity to Lead Avantor, Inc. Class Ac

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Avantor, Inc. (NYSE:AVTR) and its officers, alleging violations of federal securities laws. The lawsuit claims that Avantor issued materially false and misleading statements about its competitive position

Tone
Negative 28/100
Event
Regulatory and legal
Published
03 Jul 2026 22:41
Source
The National Law Review
Ad-hoc-news.de Direct company coverage

Avantor Inc stock highlights life sciences exposure as investors weigh long term demand

Avantor Inc. (AVTR) serves as a critical supplier to the life sciences and advanced technology industries, including biopharma manufacturers and semiconductor markets. The company's business model focuses on recurring revenue from consumables, equipment, and services used in rese

Tone
Positive 74/100
Event
Earnings
Published
03 Jul 2026 20:09
Source
Ad-hoc-news.de
The National Law Review Direct company coverage

Levi & Korsinsky Notifies Avantor, Inc. (AVTR) Investors - Lead Plaintiff Deadline on December 29, 2025

Levi & Korsinsky, LLP has announced a securities class action lawsuit filed on behalf of investors who purchased Avantor, Inc. (NYSE:AVTR) securities. The lawsuit alleges that Avantor made false statements and concealed that its competitive positioning was weaker and that it was

Tone
Negative 13/100
Event
Regulatory and legal
Published
03 Jul 2026 10:10
Source
The National Law Review
The National Law Review Direct company coverage

Securities Class Action Lawsuit Filed Against Avantor, Inc. (AVTR) - Levi & Korsinsky Represents Shareholders

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Avantor, Inc. (NYSE:AVTR) on behalf of investors who suffered losses between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor and its defendants made false statements regarding the comp

Tone
Negative 26/100
Event
Regulatory and legal
Published
01 Jul 2026 22:09
Source
The National Law Review
BioSpace Direct company coverage

Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

Avantor, Inc. (NYSE: AVTR) announced it will release its second quarter 2026 financial results before market open on Wednesday, July 29, 2026. The company will also host a conference call to discuss these results on the same day at 8:00 a.m. Eastern Daylight Time. Investors can a

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 13:10
Source
BioSpace
ACCESS Newswire Direct company coverage

Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE:AVTR) securities. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing, particularly for investors who held shares prior to

Tone
Negative 27/100
Event
Regulatory and legal
Published
30 Jun 2026 23:09
Source
ACCESS Newswire
The National Law Review Direct company coverage

Join Class Action to Recover Losses from Avantor, Inc. (AVTR) – Contact Levi & Korsinsky Before December 29, 2025

Levi & Korsinsky, LLP has filed a class action securities lawsuit against Avantor, Inc. (NYSE: AVTR) on behalf of shareholders who suffered losses between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor misrepresented its competitive position and concealed n

Tone
Negative 13/100
Event
Regulatory and legal
Published
30 Jun 2026 21:10
Source
The National Law Review
The Acquirer's Multiple Direct company coverage

Smart Money Is Buying Avantor Inc (AVTR)

Institutional investors significantly increased their stakes or initiated new positions in Avantor Inc (AVTR), a leading supplier to the life sciences industry, during the last quarter. Notable buyers include Ed Wachenheim, Joel Greenblatt, Cliff Asness, Rob Olstein, Donald Yackt

Tone
Positive 75/100
Event
Earnings
Published
30 Jun 2026 00:41
Source
The Acquirer's Multiple